The U.S. Food and Drug Administration held a Non-prescription Drug Advisory Committee meeting last week to discuss the effectiveness of oral phenylephrine as an active ingredient in over-the-counter cough and cold products that are indicated for the temporary relief of congestion, both as a single-ingredient product and in combination with other ingredients.

Two commercial health plans achieved a 5-star rating – doubling the amount from 2022 – according to the new 2023 H

Ahead of a hearing on pharmacy benefit managers before the House Committee on Oversight and Accountability on Tuesday, PhRMA released Nephron Research that contends PBMs are driving up profits and drug prices through